Unknown PHASE4 INTERVENTIONAL 1-arm NCT01329237

COMPARE-II- Vasomotion and Imaging Substudy (COMPARE-IT)

Comparison of the Everolimus Eluting (XIENCE-V® or PROMUS® Stent) With the Biolimus A9 Eluting NOBORI® Stent in All-comers: a Randomized Open Label Study The COMPARE II Trial Imaging and Vasomotion Substudy

Sponsor: University of Freiburg

Conditions Coronary Artery Disease

Interventions dynamic physical exercise and OCT imaging

Updated 5 times since 2017 Last updated: Apr 4, 2011 Started: Mar 31, 2011 Primary completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Coronary Artery Disease and is currently ongoing. University of Freiburg leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Freiburg

Data source: University of Freiburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fribourg, Switzerland